Mayo Clinic has joined SeaStar Medical as the 15th site authorised to enrol subjects for the company’s pivotal NEUTRALIZE-AKI ...

Glucarpidase significantly improved kidney function for patients who developed acute kidney injury from high-dose ...

DENVER, Jan. 22, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, ...

We are delighted that QUELIMMUNE is now available to treat severely ill children at yet another prominent academic medical center,” said Tim Varacek, SeaStar Medical Senior Vice President, Commercial ...

China: A recent case-control observational study has raised concerns about developing proteinuria in patients undergoing ...

SeaStar Medical (ICU) announces that Mayo Clinic is now cleared to enroll subjects in the company’s NEUTRALIZE-AKI pivotal trial, increasing ...

Varun Kulkarni who was seen with Shah Rukh Khan and Vicky Kaushal in Dunki is hospitalised due to kidney issues Read ahead to ...

Patients with lymphoma or leukemia with methotrexate-induced acute kidney injury experienced improved renal outcomes ...

Extracorporeal therapy (ECT) is a method of blood purification performed to remove a pathogenic substance, or solute, from ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

Background: Patients on anti-tuberculosis treatment may develop acute kidney injury (AKI), but little is known about the renal outcome and prognostic factors, especially in an aging population.

The results of this cohort study suggest that individuals with type 2 diabetes who initiated treatment with empagliflozin or ...